Why the study?
Little was known about the clinical outcomes of acute myocardial infarction in patients with a history of malignant tumor.
Does a history of malignant tumor worsen clinical outcomes (all-cause mortality and ADHF readmission) in patients with acute myocardial infarction undergoing primary PCI?
Does a history of malignant tumor worsen clinical outcomes (all-cause mortality and ADHF readmission) in patients with acute myocardial infarction undergoing primary PCI?
Answers are grounded in this paper and cite their sources.
A history of malignant tumor in patients presenting with AMI undergoing primary PCI is an independent predictor of increased all-cause mortality and readmission for acute decompensated heart failure.
BACKGROUND: Little is known about the clinical outcomes of acute myocardial infarction (AMI) in patients with a history of malignant tumor (MT). PATIENTS AND METHODS: We retrospectively studied 1,295 consecutive patients with AMI who underwent primary percutaneous coronary intervention within 24 hours of onset. The patients were divided into two groups: those with a history of MT (MT group, n=50) and those without (non-MT group, n=1,245). RESULTS: The MT group was older, and had lower hemoglobin, total protein, and albumin levels. All-cause mortality and re-admission rates due to acute decompensated heart failure (ADHF) were significantly higher in the MT group. Multivariate analysis showed that a history of MT was an independent predictor for all-cause mortality and re-admission due to ADHF. CONCLUSION: The clinical outcomes of patients with AMI with a history of MT are poor, and a history of MT is an independent predictor for all-cause mortality and re-admission due to ADHF. These patients may need careful risk management for heart failure to avoid re-admissions due to ADHF.
No takes yet. Share an insight, caveat, or question.
Nozaka et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: